HIV Patients and EBV-Specific CD4+ T Cell Function in CNS Lymphoma
Author Information
Author(s): Gasser Olivier, Bihl Florian K, Wolbers Marcel, Loggi Elisabetta, Steffen Ingrid, Hirsch Hans H, Günthard Huldrych F, Walker Bruce D, Brander Christian, Battegay Manuel, Hess Christoph
Primary Institution: University Hospital Basel
Hypothesis
Do CD4+ T Cell Functional Responses to Epstein-Barr Virus Provide Protective Immunity Against CNS Lymphoma in AIDS?
Conclusion
HIV-positive patients who developed PCNS lymphoma lacked EBV-specific CD4+ T cell function, regardless of their absolute CD4+ T cell counts.
Supporting Evidence
- 0 out of 6 patients with PCNS lymphoma had an EBV-specific CD4+ T cell response.
- 13 out of 16 matched controls had detectable EBV-specific CD4+ T cell responses.
- PCNS lymphoma patients had similar CMV-specific CD4+ T cell responses compared to controls.
Takeaway
People with HIV who get a brain cancer called PCNS lymphoma don't have the special immune cells that help fight a virus called EBV, even if their overall immune cell count looks normal.
Methodology
A case-control study comparing EBV-specific CD4+ T cell function in HIV-positive patients with PCNS lymphoma to matched controls and HIV-negative donors.
Potential Biases
Potential selection bias due to the small number of cases identified.
Limitations
The study had a small sample size and was retrospective, which may limit the generalizability of the findings.
Participant Demographics
Six HIV-positive individuals with PCNS lymphoma and 16 matched HIV-positive controls, plus 11 HIV-negative blood donors.
Statistical Information
P-Value
0.007
Confidence Interval
[0–0.40]
Statistical Significance
p<0.001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website